NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura...
24 insider purchases on record · latest filing 2024-12-18.
Insiders have also filed 12 sale transactions at NRXP.